Featured Article

An artificial intelligence generated model of the infant gut microbiome can help predict developmental risks at an early stage.

Precision Oncology Today


Sequencing Spatially-Located Single Cells

New combinations of technology help scientists understand biology and disease more than ever, but much more lies ahead.
AI Brain Concept

Beginning a New Era of Precision Alzheimer’s Therapeutics

Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
Science template, abstract background with a 3D DNA molecules

5 Startups With Proteomics Potential Attracting Investor Cash

Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...

Trending on Inside Precision Medicine

cancer cell

Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes 

Genialis' krasID is an RNA-based biomarker that uses machine learning to model fundamental aspects of KRAS cancer biology to predict tumor response to and clinical benefit of KRAS inhibitors. 
X-ray style image of the top part of a woman's body showing the lungs highlighted and four red lung cancer tumors of different sizes

Liquid Biopsy: A New Frontier in Small-Cell Lung Cancer Management

Researchers develop a liquid biopsy test able to distinguish between different types of lung cancer, improving diagnosis and treatment.
Genetic Research, DNA profile reflected in a test tube containing a sample

MassMutual Expands Voluntary Genetic Testing Program

Under an expanded program, more MassMutual policy holders will be offered saliva-based tests from Genomics that generate polygenic risk scores for nine common preventable conditions.

Daily News

Related Content

Inside Precision Medicine